Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1998;82:451-457

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ladilov, Y. V.
Right arrow Articles by Piper, H. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ladilov, Y. V.
Right arrow Articles by Piper, H. M.
(Circulation Research. 1998;82:451-457.)
© 1998 American Heart Association, Inc.


Original Contributions

Protection of Rat Cardiomyocytes Against Simulated Ischemia and Reoxygenation by Treatment With Protein Kinase C Activator

Y. V. Ladilov, C. Balser, , H. M. Piper

From the Physiologisches Institut, Justus-Liebig-Universität, Giessen, Germany.

Correspondence to Prof H.M. Piper, Physiologisches Institut, Justus-Liebig-Universität, Aulweg 129, D-35392 Giessen, Germany. E-mail michael.piper{at}physiologie.med.uni-giessen.de

Abstract—The aim of this study was to investigate whether treatment with the protein kinase C (PKC) agonist 1,2-dioctanoyl-sn-glycerol (1,2DOG) can protect isolated adult Wistar rat cardiomyocytes against simulated ischemia and reoxygenation. Cytosolic Ca2+ (assessed by fura 2 fluorescence), pHi (assessed by BCECF fluorescence), and cell length were measured during 80 minutes of simulated ischemia (anoxia, pHo 6.4) and 20 minutes of reoxygenation (pHo 7.4) and compared between control cells and cells treated with 20 µmol/L 1,2DOG before anoxia (10-minute treatment and 10-minute washout), before and during anoxia (two-step treatment), or only during anoxia. Treatment before anoxia attenuated rigor contracture but did not influence anoxic Ca2+ overload. In contrast, two-step treatment before and during anoxia accelerated rigor contracture but reduced the rate of anoxic Ca2+ accumulation. During reoxygenation, control cells developed irreversible hypercontracture (reduction of cell length to 43±2% of the initial cell length, n=62), which was accompanied by spontaneous oscillations of cytosolic Ca2+ (19.6±1.6 per minute). Two-step treatment with 1,2DOG before and during anoxia significantly reduced hypercontracture (reduction of cell length to 60±2%, P<.01 versus control, n=41) and suppressed spontaneous Ca2+ oscillations (2.8±0.9 per minute, P<.01 versus control). These effects could not be reproduced by treatment with 1,2DOG before anoxia or during anoxia or by a two-step treatment with the PKC-inactive 1,3-dioctanoyl-sn-glycerol and were fully abolished with 1 µmol/L bisindolylmaleimide (PKC inhibitor). We conclude that a two-step activation of PKC before and during anoxia is required for effective protection of cardiomyocytes against anoxic Ca2+ overload and reoxygenation-induced hypercontracture.


Key Words: protein kinase C • dioctanoyl-sn-glycerol • cardiomyocyte • ischemia • reoxygenation




This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
T.-T. Pan, K. L. Neo, L.-F. Hu, Q. C. Yong, and J.-S. Bian
H2S preconditioning-induced PKC activation regulates intracellular calcium handling in rat cardiomyocytes
Am J Physiol Cell Physiol, January 1, 2008; 294(1): C169 - C177.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Ladilov, H. Maxeiner, C. Wolf, C. Schafer, K. Meuter, and H. M. Piper
Role of protein phosphatases in hypoxic preconditioning
Am J Physiol Heart Circ Physiol, September 1, 2002; 283(3): H1092 - H1098.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C Schafer, Y Ladilov, J Inserte, M Schafer, S Haffner, D Garcia-Dorado, and H.M Piper
Role of the reverse mode of the Na+/Ca2+ exchanger in reoxygenation-induced cardiomyocyte injury
Cardiovasc Res, August 1, 2001; 51(2): 241 - 250.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Tani, Y. Honma, H. Hasegawa, and K. Tamaki
Direct activation of mitochondrial KATP channels mimics preconditioning but protein kinase C activation is less effective in middle-aged rat hearts
Cardiovasc Res, January 1, 2001; 49(1): 56 - 68.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
I. Jeremias, C. Kupatt, A. Martin-Villalba, H. Habazettl, J. Schenkel, P. Boekstegers, and K. M. Debatin
Involvement of CD95/Apo1/Fas in Cell Death After Myocardial Ischemia
Circulation, August 22, 2000; 102(8): 915 - 920.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S.-F. Yan, J. Lu, Y. S. Zou, W. Kisiel, N. Mackman, M. Leitges, S. Steinberg, D. Pinsky, and D. Stern
Protein Kinase C-beta and Oxygen Deprivation. A NOVEL Egr-1-DEPENDENT PATHWAY FOR FIBRIN DEPOSITION IN HYPOXEMIC VASCULATURE
J. Biol. Chem., April 14, 2000; 275(16): 11921 - 11928.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. Tian, W. Miao, M. Spindler, M. M. Javadpour, R. McKinney, J. C. Bowman, P. M. Buttrick, and J. S. Ingwall
Long-term expression of protein kinase C in adult mouse hearts improves postischemic recovery
PNAS, November 9, 1999; 96(23): 13536 - 13541.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. G. Maddaford, C. Hurtado, S. Sobrattee, M. P. Czubryt, and G. N. Pierce
A model of low-flow ischemia and reperfusion in single, beating adult cardiomyocytes
Am J Physiol Heart Circ Physiol, August 1, 1999; 277(2): H788 - H798.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. F. Stowe
Understanding the temporal relationship of ATP loss, calcium loading, and rigor contracture during anoxia, and hypercontracture after anoxia in cardiac myocytes
Cardiovasc Res, August 1, 1999; 43(2): 285 - 287.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
Y. V. Ladilov, C. Balser-Schafer, S. Haffner, H. Maxeiner, and H.M. Piper
Pretreatment with PKC activator protects cardiomyocytes against reoxygenation-induced hypercontracture independently of Ca2+ overload
Cardiovasc Res, August 1, 1999; 43(2): 408 - 416.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Ladilov, S. Haffner, C. Balser-Schafer, H. Maxeiner, and H. M. Piper
Cardioprotective effects of KB-R7943: a novel inhibitor of the reverse mode of Na+/Ca2+ exchanger
Am J Physiol Heart Circ Physiol, June 1, 1999; 276(6): H1868 - H1876.
[Abstract] [Full Text] [PDF]